Role of initial and follow-up IL-6 (interleukin-6) titre in COVID-19 pneumonia: a single center experience
Electronic Journal of General Medicine
; 19(5), 2022.
Artículo
en Inglés
| CAB Abstracts | ID: covidwho-2275881
ABSTRACT
Background:
Robust data of IL-6 is available in bacterial infection, and now it can be utilized in currently ongoing COVID-19 (corona virus disease-19) pneumonia pandemic to guide treatment strategy as marker of inflammation.Methods:
Prospective, observational study included 1,000 COVID-19 cases confirmed with RT PCR (reverse transcription polymerase chain reaction). All cases were undergone categorized after clinical details, HRCT (high resolution computerized tomography) thorax, oxygen saturation, IL-6 (interleukin 6) at entry point and follow up. Age, gender, comorbidity and use BIPAP/NIV (bilevel positive airway pressure/non-invasive ventilation), and outcome as with or without lung fibrosis as per HRCT severity were key observations. Statistical analysis is done by using Chi-square test.Results:
In study of 1,000 COVID-19 pneumonia cases, age (<50 and >50 years) and gender has significant association with IL-6. HRCT severity score at entry point has significant correlation with IL-6 level (p < 0.00001). IL-6 level has significant association with duration of illness (p < 0.00001). Comorbidities has significant association with IL-6 level (p < 0.00001). IL-6 level has significant association with oxygen saturation (p < 0.00001). BIPAP/NIV requirement has significant association with IL-6 level (p < 0.00001). Timing of BIPAP/NIV requirement during course of hospitalization has significant association with IL-6 level (p < 0.00001). Follow-up IL-6 titer during hospitalization as compared to entry point normal and abnormal IL-6 has significant association with post-COVID-19 lung fibrosis, respectively (p < 0.00001).Conclusion:
IL-6 has very crucialrole in COVID-19 pneumonia in predicting severity of illness, progression of illness including 'cytokine storm' and assessing response to treatment during hospitalization and follow-up titers in analyzing post-COVID-19 lung fibrosis.
Human Immunology and Allergology [VV055], Prion; Viral; Bacterial and Fungal Pathogens of Humans [VV210], Mathematics and Statistics [ZZ100], Molecular Biology and Molecular Genetics [ZZ360], adults, age, artificial respiration, comorbidity, computed tomography, coronavirus disease 2019, diagnostic techniques, disease course, elderly, fibrosis, health care, health protection, hospital admission, human diseases, interleukin 6, lower respiratory tract infections, lungs, middle-aged adults, observational studies, pandemics, pneumonia, respiration, respiratory diseases, sex, statistical analysis, viral diseases, man, Severe acute respiratory syndrome coronavirus 2, Homo, Hominidae, primates, mammals, vertebrates, Chordata, animals, eukaryotes, Severe acute respiratory syndrome-related coronavirus, Betacoronavirus, Coronavirinae, Coronaviridae, Nidovirales, positive-sense ssRNA Viruses, ssRNA Viruses, RNA Viruses, viruses, disease progression, aged, elderly people, older adults, senior citizens, lung diseases, SARS-CoV-2, statistical methods, viral infections
Texto completo:
Disponible
Colección:
Bases de datos de organismos internacionales
Base de datos:
CAB Abstracts
Tipo de estudio:
Estudio de cohorte
/
Estudio pronóstico
Idioma:
Inglés
Revista:
Electronic Journal of General Medicine
Año:
2022
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS